NCT04136548View on ClinicalTrials.gov

Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Fentanyl

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

November 18, 2020

Study Completion Date

November 18, 2020

Conditions
Healthy
Interventions
DRUG

Fentanyl

Subjects will receive 75 ug Fentanyl while the effects of this drug on tolerance to a hemorrhagic insult will be assessed.

OTHER

Placebo

Subjects will receive saline while the effects of this drug on tolerance to a hemorrhagic insult will be assessed.

Trial Locations (1)

75390

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

University of Texas Southwestern Medical Center

OTHER

NCT04136548 - Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Fentanyl | Biotech Hunter | Biotech Hunter